Related Experiment Video
Updated: Jul 24, 2025

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
Antipsychotic Medication Use In Medicaid-Insured Children Decreased Substantially Between 2008 And 2016
Greta Bushnell1, James Lloyd2, Mark Olfson3
1Greta Bushnell (greta.bushnell@rutgers.edu), Rutgers University, New Brunswick, New Jersey.
Insights
Pediatric antipsychotic prescribing significantly declined between 2008 and 2016, with usage decreasing across all demographic groups. This trend suggests a move toward more appropriate medication use in children covered by Medicaid.
Area of Science:
- Pediatric psychopharmacology
- Health services research
- Public health policy
Background:
- Concerns over the rapid increase in pediatric antipsychotic prescribing, particularly among Medicaid beneficiaries, prompted safety and appropriateness reviews.
- State-level policy and educational initiatives were implemented to encourage safer and more judicious antipsychotic use in children.
- Previous trends showed antipsychotic use leveling off, but recent national data on pediatric Medicaid populations were lacking, especially regarding racial and ethnic variations.
Purpose of the Study:
- To estimate national trends in antipsychotic use among children (ages 2-17) enrolled in Medicaid from 2008 to 2016.
- To examine variations in antipsychotic prescribing trends by demographic factors, including race and ethnicity.
- To assess changes in the proportion of children receiving antipsychotics for FDA-approved pediatric indications.
Main Methods:
- Analysis of a national Medicaid prescription claims database.
- Longitudinal study design examining trends from 2008 to 2016.
- Stratification of data by age, sex, race, ethnicity, and foster care status.
Main Results:
- A significant decline in antipsychotic use was observed among children aged 2-17 in the Medicaid population between 2008 and 2016.
- Declines in antipsychotic prescribing were consistent across various demographic subgroups, including race and ethnicity.
- The percentage of children with an antipsychotic prescription who had a diagnosis for an FDA-approved pediatric indication increased from 38% in 2008 to 45% in 2016.
Conclusions:
- Antipsychotic prescribing among children in the Medicaid population has substantially decreased over the study period.
- This decline, coupled with an increase in use for approved indications, suggests a positive shift towards more judicious prescribing practices.
- Further research may explore the long-term impact of these trends on child mental health outcomes.
Abstract:
After the rapid growth of pediatric antipsychotic prescribing in the early 2000s, especially in the Medicaid population, concerns regarding the safety and appropriateness of such prescribing increased. Many states implemented policy and educational initiatives aimed at safer and more judicious antipsychotic use. Antipsychotic use leveled off in the late 2000s, but there have been no recent national estimates of trends in antipsychotic use in children enrolled in Medicaid, and it is unclear how use varied by race and ethnicity. This study observed a sizable decline in antipsychotic use among children ages 2-17 between 2008 and 2016. Although the magnitude of change varied, declines were observed across foster care status, age, sex, and racial and ethnic groups studied. The proportion of children with an antipsychotic prescription who received any diagnosis associated with a pediatric indication that was approved by the Food and Drug Administration increased from 38 percent in 2008 to 45 percent in 2016, which may indicate a trend toward more judicious prescribing.
More Related Videos
12:00Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization
Published on: November 19, 2014
15:00Setup of Consumer Wearable Devices for Exposure and Health Monitoring in Population Studies
Published on: February 3, 2023
Related Concept Videos
Drug Therapy
Antianxiety Medications
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Goals of Pharmacotherapy
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Mania and Antimanic Drugs: Overview
Factors Affecting Drug Response: Overview